Impact Of Gain-Of-Function Mutations In The Low-Density Lipoprotein Receptor Related Protein 5 (lrp5) On Glucose And Lipid Homeostasis
|
|
- Rose Franklin
- 5 years ago
- Views:
Transcription
1 Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2014 Impact Of Gain-Of-Function Mutations In The Low-Density Lipoprotein Receptor Related Protein 5 (lrp5 On Glucose And Lipid Homeostasis Dinah Foer Yale School of Medicine, dinah.foer@yale.edu Follow this and additional works at: Recommended Citation Foer, Dinah, "Impact Of Gain-Of-Function Mutations In The Low-Density Lipoprotein Receptor Related Protein 5 (lrp5 On Glucose And Lipid Homeostasis" (2014. Yale Medicine Thesis Digital Library This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar A Digital Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
2 Impact of gain-of-function mutations in the low-density lipoprotein receptor related protein 5 (LRP5 on glucose and lipid homeostasis A Thesis Submitted to the Yale University School of Medicine in Partial Fulfillment of the Requirements for the Degree of Doctor of Medicine by Dinah Foer 2014
3 IMPACT OF GAIN-OF-FUNCTION MUTATIONS IN THE LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5 (LRP5 ON GLUCOSE AND LIPID HOMEOSTASIS. Dinah Foer, Meiling Zhu, Christine Simpson, Grace Lee, Rebecca Sullivan, and Karl L. Insogna. Section of Endocrinology, Department of Internal Medicine, Yale University, School of Medicine, New Haven, CT. Investigations in animal models suggest a physiologic link between LRP5 and glucose and lipid homeostasis. However, the data in human studies is far from consensus. While LRP5 has been shown to be critical to Wnt signaling, the molecular mechanism for the effect on metabolism is unknown. We hypothesize that a high bone mass (HBM mutation in LRP5 will lead to improved glucose and lipid homeostasis. We aim to measure the impact of these mutated receptors on human glucose and lipid metabolism and to investigate the pathway(s by which Wnt may affect glucose metabolism in vitro. Eleven subjects with HBM-causing LRP5 mutations were matched by gender, age, and body mass index (BMI to 22 unrelated control subjects. Hemoglobin A1c (HbA1c, estimated average glucose (eag, HOMA-B, HOMA-IR, and lipid panel were analyzed. An oral glucose tolerance test and 1 HMRS study of liver and skeletal muscle were performed on a subset of affected patients. Primary hepatocytes and HepG2 cells were treated in vitro with Wnt3a, and PEPCK-C mrna expression was measured by QPCR. INS-1 cells and human pancreatic islet beta-cells were assayed for glucose-stimulated insulin secretion using an ELISA technique. Statistical differences were analyzed using the unpaired Student t-test and one-way ANOVA. There were no statistically significant differences between affected and control populations for HbA1c, eag, insulin, HOMA-B and HOMA-IR. Differences in total cholesterol, triglycerides, and HDL, were not significant. However, LDL levels were significantly lower in affected subjects (p=0.04. Wnt did not effect PEPCK-C expression. Wnt did not significantly effect glucose-stimulated insulin secretion in INS-1 cells and human islets. In summary, this is the first investigation on the metabolic consequences of LRP5 mutations in human kindreds with HBM-causing mutations. Our data does not support the hypothesis that LRP5 improves glucose metabolism in these individuals. The data does suggest that there may be a specific, beneficial effect of LRP5 on LDL cholesterol, however additional studies need to be done to confirm the effect and elucidate the mechanism.
4 Acknowledgements.. ThisthesiswouldnothavebeenpossiblewithouttheinspiredparticipationoftheLRP5 kindredmembers.iamespeciallygratefulfortheenthusiasmofthelatedr.johnpackard, Sr.,Dr.JohnPackard,Jr.,andthecontinuedcommitmentofthenextgenerations. ThankyoutotheoutstandingYalescientistswhohelpedtostrengthenanddeepenthis work:dr.richardkibbeyandrebeccapongratzfortheirgenerositywithmaterials, knowledge,andcollaboration;anddr.kittfalkpetersenforherextraordinaryhelpwiththe OGTTandMRSstudies.ThankyoutoDr.ThomasCarpenterforhisinsightfulcomments duringthethesisreviewprocess. ThankyoutothewonderfulwomenoftheInsognaLab:MeilingZhu,BeckySullivan, ChristineSimpson,GraceLee,IreneSherman,CarrieThomas,JessicaBihuniak.Thankyouto BenhuaSunwhotaughtmehowtouseapipette Dr.KarlInsognahasbeenanexceptionalmentor,teacher,advocateandrolemodelforme overthepastfiveyears.iamdeeplygratefulforthetime,energyandconfidencehehas investedinmeandinthisproject. IamgratefulforthegenerousfundingprovidedbytheYaleOfficeforStudentResearch throughmultiplegrants.thisworkwassupportedbyanationalinstitutesofhealthtnhlbi MedicalStudentResearchFellowship,andfundingfromtheNationalCenterForAdvancing TranslationalSciencesoftheNationalInstitutesofHealthunderAwardNumber TL1TR Thecontentissolelytheresponsibilityoftheauthoranddoesnot necessarilyrepresenttheofficialviewsofthenationalinstitutesofhealth. ThisthesisworkisdedicatedtoMeilingZhu,atrulyhumble,andgiftedteacher.
5 TABLE&OF&CONTENTS& & & Introduction.1 StatementofPurpose,Hypothesis,SpecificAims. 8 Methods... 9 HumanStudies..10 In#vitro#studies Results HumanStudies.. 18 In#vitro#studies Discussion. 24 Conclusion Figures&Tables...31 References....44
6 1 INTRODUCTION Thelowdensitylipoproteinrelatedprotein5(LRP5cametoclinicalattentionin 2001whenGongandcoworkersreportedthatlossoffunctionmutationsinthis receptorcausedprofoundosteoporosisandfractures(gongetal.,2001.in2002, YaleUniversityinvestigatorsreportedthatamutationinLRP5thatconferred resistancetoendogenousinhibitorssuchasdkk1,causedanotherdramaticskeletal phenotype.akindredwasidentifiedwithaninheritedsyndromeofhighbonemass thatwasphenotypicallycharacterizedbyareducedangleofthejaw,toruspalatinus, andextremelyhighbonedensitywhenmeasuredbydualenergyxray absorptiometry(boydenetal.,2002.thesyndromewasinheritedinanautosomal dominantpattern.interestingly,membersofthekindredreporteddifficultystaying afloatwhileswimming.affectedfamilymemberswereshowntohaveasinglebase pairmutationcausingaglycinetovalinechangeatposition171.glycine171is evolutionarilyconservedinlrp5andinitshomologues,indicatingacriticalrolefor thisresidue(heyetal.,1998.subsequentlyadditionalhighbonemass(hbm causingmutationsinlrp5havebeenidentifiedinotherkindreds(vanwesenbeeck etal.,2003;whyte,reinus,&mumm,2004.theexactmechanismbywhichthese highbonemasscausingmutationsleadtothephenotypedescribedisnot completelyunderstood.howeverasnoted,thelrp5g171vmutationisresistantto theactionsoftheendogenousinhibitordickopf1(dkk1.thus,whilethereceptor doesnotsignalintheabsenceofligandandappearstosignalnormallyinthe presenceofligand,whendkk1isaddedliganddependentsignalingislargely unaffected(boydenetal.,2002.
7 2 TheroleofLRP5skeletalhomeostasisisnowwellestablished(Williams&Insogna, 2009.Morerecently,animalmodelswithbothHBMandlowbonemass(LBM causingmutations,aswellashumanstudiesinpopulationswithlbmcausing mutations,implicatearoleforlrp5inglucosemetabolismandlipidhomeostasis (Fujinoetal.,2003;Saarinenetal.,2010.ThisintroductionwillreviewLRP5 s functionanditskeysignalingpathways,providingabackgroundforunderstanding thepotentialroleoflrp5inhumanmetabolism. LRP5.&TheLRP5geneislocatedonchromosome11q13.4.Theencodedproteinin vertebratesisasinglepasstransmembranemoleculethatisareceptorforlow densitylipoprotein(ldl(galoraetal.,2013.theproteinalsoservesasaco receptor,alongwithitshomologuelrp6andthefamilyoffrizzledtransmembrane receptors,forthewinglesstypemmtvintegrationsitefamilyofglycoproteins, commonlydenotedaswntproteins.thewntgenes,ofwhichtherearecurrently nineteen,encodesecretedglycoproteins,generatingsignaltransductioncascades thatarecriticaltonearlyeveryeventduringdevelopment(moon,2005.wnt signalingpersistspostnatallytoregulateexpressionofspecifictargetgenesinself renewingadulttissuessuchasgut,hairfollicle,bone,andthehematopoieticsystem. MutationsinWntsignalinghavesubsequentlybeenidentifiedinoncogenesis, notablyincoloncancerandliquidcancers(reya&clevers,2005,andisanactive areaofcancerresearch. & &
8 3 Wnt&signaling&pathways.&&ThreepathwaysareactivatedfollowingWntreceptor engagement:thecanonicalwntpathway,thenoncanonicalplanarcellpolarity pathway(pcp,andthewnt/ca 2+ pathway.thecanonicalpathwayisthebest studiedofthese(clevers,2006.inthispathway,wntligandsbindtoafrizzled/lrp complex,interactingwithdashandaxinproteins,andpreventingtheproteosomal degradationofbetacatenin,whichplaysamajorroleinthecanonicalpathway.as justnoted,intheabsenceofwntsignaling,betacateninistargetedfor phosphorylationdependentdestruction.stabilizedandunphosphorylated,beta5 cateninaccumulatesinthecytoplasmandtranslocatestothenucleuswhereitbinds transcriptionfactorsandtranscriptionallyactivatesawiderangeoftargetgenes (Tamaietal.,2004.SecretedDkkproteinsinhibitWntsignalingbydirectbindingto LRP5/6,promotinginternalizationandinactivationofthereceptors(Tamaietal., 2000.& & Bone.&&TheroleofLRP5inboneaccrualiswellestablished.InosteoblastsLRP5 transduceswntsignalingviathecanonicalpathway.lrp5deficientmice demonstratelowbonemassasaresultofimpairedboneformationattributableto defectsinosteoblastproliferationandmaturation(katoetal.,2002.ofnote,lrp5 deficientmicealsodemonstratepersistentembryoniceyevascularizationasaresult offailedmacrophagemediatedapoptosis.conversely,transgenicmiceexpressinga gainoffunctionlrp5alleleinosteoblastshaveincreasedbonedensityand increasedosteoblastactivity(babijetal.,2003.&
9 4 Asnoted,humanshomozygousforlossoffunctionmutationsinLRP5areconsistent withobservationsinanimalmodels.theseindividualshaveanautosomalrecessive disorder,osteoporosispseudoglioma(oppgsyndrome,characterizedbysevere osteoporosis,childhoodfracturesandblindnessduetoabnormalvitreous development(gongetal.,2001.commonpolymorphicvariantsinlrp5inavariety ofhumanethnicpopulationsandagegroupshavebeenshowntoinfluencebone densityinthegeneralpopulation,indicatingthatinadditiontoitsroleintherare inheritedsyndromesjustdescribed,ithasanimportantroleinregulatingnormal skeletalmetabolism(jiangetal.,2010;saarinenetal.,2010;zenibayashietal., ConsistentwithacriticalroleofWntsignalinginbonehomeostasisaretheskeletal phenotypesobservedwithlossoffunctionmutationsintheendogenousinhibitors ofwntsignalingdkk1(describedaboveandsclerostin.heterozygouslossof functionmutationsindkk1leadtohighbonemassinmice(morvanetal.,2006.in humans,lossoffunctionmutationsinsclerostinleadtoaconditioncalled sclerosteosis,characterizedbymassiveandprogressiveincreasesinbonemass resultingultimatelyinnerveentrapment(lietal.,2005;semenov,tamai,&he, Lipid&Homeostasis.&&AnimalmodelsofLRP5deficiencydemonstrateimpairedlipid homeostasisundercertainexperimentalconditions.lrp5deficientmicefedahigh fatdietdevelopedhighplasmacholesterollevels,markedbyimpairedhepatic
10 5 clearanceofchylomicronremnants.whenfedanormaldiet,thesemicehadnormal plasmalipidlevels(fujinoetal.,2003.however,micedeficientinbothapoeand LRP5fedanormaldietexhibitedapproximately60%higherplasmacholesterol levelscomparedwithapoeknockoutmice.analysisoflipidcomponentsshowed thatplasmaclearanceofdietderivedtriglycerideswasseverelyimpairedbylrp5 butnotapoedeficiency.thesedatasuggestthatinamurinemodel,lrp5mediates catabolismofplasmalipoproteinsthroughapoedependentandindependent mechanisms(magoorietal.,2003.& Inhumanstudies,animpactofLRP5onlipidmetabolismislesswellestablished. TwosinglenucleotidepolymorphismsinLRP5havebeenassociatedwithahigher riskforofabdominalaorticaneurysm.specifically,thesepolymorphismsresultin reducedexpressionoflrp5causingimpairedclearanceoflipoprotein(a,an atherothromboticriskfactor(giustietal.,2009.astudyofachinesehan populationfoundanassociationbetweentwosinglenucleotidepolymorphismsin LRP5andincreasedcirculatinglevelsoftotalcholesterol(Jiangetal.,2010.Ina prepubertalfinnishpopulation,variantsinlrp5wereassociatedwithhighertotal andldlcholesterollevels(lappalainenetal.,2009.however,incontrast,astudy of13finnishindividualsfromonefamilywiththreedifferentlbmcausinglrp5 mutationsdidnotdemonstratehypercholesterolemiaorelevatedtriglyceridelevels (Saarinenetal.,2010. ThefindingsofabnormallipidmetabolisminmurinemodelsofLRP5deficiencyand
11 6 insomehumanstudies,incombinationwiththeroleoflrp5inosteoporosis,have promptedinvestigationoflrp5asacandidategeneunderlyingthemetabolic syndrome.findingsfromonestudyinacaucasianpopulationsuggestedan associationofsnpsandhaplotypesinthelrp5gene,withobesity,althoughthe molecularmechanismwasnotdefined(guoetal.,2006.incontrast,astudyina Japanesepopulation,whichincludedthesameSNP,didnotfindanassociation betweenbodymassindex(bmiandthatsamepolymorphismorhaplotypes comprisingit.furthermore,otherstudieshavefoundnoevidenceofanassociation betweenlrp5polymorphismsandbmi,homeostaticmodelassessmentof estimatedbetacellfunction(homab,estimatedinsulinresistance(homair,or serumlipidsindiabeticversusnondiabeticcontrols(zenibayashietal.,2008. Consistentwiththis,Jingetal(mentionedabovefoundnoassociationofLRP5 polymorphismswithbmi(jiangetal.,2010. Glucose&metabolism.ApotentialroleforLRP5inglucosemetabolismwasfirst reportedinananimalmodel.lrp5deficientmice,fedanormaldiet,werefoundto haveimpairedglucosetoleranceandbluntedglucoseinducedinsulinsecretionby isolatedpancreaticbetacells.isletsisolatedfromthesemicehadreduced intracellularlevelsatpandca 2+, anddecreasedmrnalevelsofinsulinsignaling targetsincludingglucokinaseandhnf4understimulatoryconditions.wnt3afailed toinduceinsulinsecretioninlrp5deficientislets,whileinwildtypeisletsboth Wnt3aandWnt5astimulatedglucoseinducedinsulinsecretion(Fujinoetal., 2003.&
12 7 ThesuggestedlinkbetweenLRP5andglucosemetabolismpromptedarangeof humanstudies.however,findingstodatehavebeenlessdefinitivethanthosein animalmodels.nostatisticallysignificantassociationshavebeenfoundbetween geneticpolymorphismsinlrp5andglucosemetabolism,asassessedby HemoglobinA1c(HbA1c(Jiangetal.,2010,HOMAB,orHOMAIR,wasfoundin individualswithtype2diabetesorinnondiabeticsubjects(lappalainenetal., 2009;Zenibayashietal.,2008.However,thesinglenucleotidepolymorphismsthat giverisetothehbmphenotypeshaveneverbeenincludedinanyoftheseanalyses fortheobviousreasonthattheirfrequencyinthegeneralpopulationisexceedingly rare.astudyoffinnishindividualswhowerehomozygous,compound heterozygous,orheterozygousforthreedifferentdeletionallbmcausinglrp5 mutations,foundthatapproximately50%ofthesesubjectshaddiabetes,with abnormalitiesreportedineitherbloodhba1clevelsorinoralglucosetolerance tests(ogtt(saarinenetal.,2010.thosewithabnormalogttshadlowfirst phaseinsulinreleasebutwerenotinsulinresistant.theseinterestingobservations arelimitedbythelackofacontrolpopulation.forexample,thispopulationincluded overweightpatientsaswellaspatientswithsignificantcomorbidities,thatcould haveconfoundedtheresult.thestudyalsolackedstatisticalpowertodetect potentialdifferencesinmetabolicparameters. & LRP6.&WhilethisthesisfocusesonLRP5anditsroleinhumanmetabolism,recent studieshaveelucidatedaroleforlrp6infuelmetabolism.manietal.identifieda nonconservativelossoffunctionmutationinlrp6thatattenuatestranscription
13 8 factor7like2(tcf7l2dependenttranscriptionoftheinsulinreceptorgene(singh etal.,2013.affectedindividualshaveasyndromeofearlyonsettype2diabetes, coronaryarterydisease,metabolicsyndrome,andosteoporosisinheritedinan autosomaldominantpattern.carriersexhibithyperinsulinemiaandreducedinsulin sensitivityinperipheraltissues,particularlyskeletalmuscle,whichcanbedetected priortothedevelopmentofimpairedglucosetolerance(manietal.,2007. & STATEMENTOFPURPOSE,HYPOTHESIS,SPECIFICAIMSOFTHESIS AsreviewedintheIntroduction,studiesinanimalssuggestaphysiologiclink betweenlrp5andmetabolism.however,thereisnoconsensusopinioninhuman studies.inadditiontherehavebeennohumanstudiesonthemetabolic consequencesofhbmcausinglrp5mutations.thisthesisexplorestheroleoflrp5 inhumanglucoseandlipidmetabolismbystudyingvolunteerswithhbmcausing LRP5mutations.StudiesinthispopulationcouldprovideinsightsintoLRP5 srole,if any,incommondiseasessuchasdiabetesandhypercholesterolemia. WehypothesizethattheLRP5pathwayhasasimilarroleinhumans,asinmice,and thathbmcausinglrp5mutationsinhumanswillleadtoimprovedglucose homeostasisandlipidmetabolismcomparedtomatchedcontrols.thespecificaims ofthisthesisareto: 1.MeasuretheimpactofHBMcausingmutationsinLRP5onhumanglucoseand lipidmetabolism 2.Investigatethepathway(sbywhichWntmayaffectglucosemetabolismin&vitro
14 9 METHODS Study&Subjects.NinesubjectswiththeG171VHBMcausingLRP5mutationwere recruitedfromtwopreviouslyreportedkindreds(fig.1a,fig.1b(boydenetal., 2002;Leeetal.,2013.TwosubjectswithanN198S(asparaginetoserinemutation inlrp5associatedwithhbmwerealsostudied(leeetal.,2013.wealsorecruited 22gender,age,race,andbodymassindex(BMImatchedindividualsunrelatedto thekindredmemberstoserveascontrols. HbA1candinsulinweremeasuredinallparticipants.Twocontrolsubjectsmatched forgender,age,andbmiwererecruitedforeverystudysubject.fivesubjects,in total,fromtheaffectedandcontrolgroupsreportedtakinglipidlowering medicationsandwereexcludedfromthelipidanalysisportionofthestudy.recent datasuggestalinkbetweenhmgcoareductaseinhibitoruseandtype2diabetes (Carteretal.,2013.Asthisassociationhasnotestablishedcausality,wechosenot toexcludethesefivesubjectsfromtheglucoseanalysis.threesubjectsagreedto undergoanogtt,andtwounderwentmrsstudies.thesesubjectswerematched forage,race,bmi,andactivityleveltoalargecontrolgroup(n=54. ThestudycompliedwiththeWorldMedicalAssociationDeclarationofHelsinki EthicalPrinciplesforMedicalResearchInvolvingHumanSubjects.Thestudywas approvedbytheyalehumanresearchprotectionprogramirb.allsubjectsgave writtenconsenttoparticipateinthestudyafterthepurpose,natureandpotential risksofthestudieswereexplained.
15 10 IHumanStudies Theauthorofthisthesisrecruited,enrolledandstudiedallvolunteerswhosedata arereportedhereunlessotherwisespecified. Hemoglobin&A1c.Participantswereinstructedtofastfrommidnightonward.All bloodsamplingtookplacebetween7am10amontheyalenewhavenhospital ResearchUnit.HbA1cwasmeasuredinwholebloodbytheYaleNewHavenClinical ImmunologyLab,usingPremierHb9210boronateaffinityhighperformanceliquid chromatographywitheluatesmeasuredat413±2nmabsorbanceaccordingto manufacturersinstructions(trinitybiotech;jamestown,ny. Insulin.PlasmaconcentrationsofinsulinweremeasuredwithaHumanInsulin SpecificRIAKit(Millipore;St.Charles,MOintheYaleMineralMetabolism Laboratory.HOMABandHOMAIRweremathematicallyderivedfromthe measuredinsulinvalueandtheestimatedaverageglucose(eagfromthesame bloodsample(nathanetal.,2008. OGTT.WholebodyinsulinsensitivitywasassessedincollaborationwithDr.Kitt FalkPetersen(YaleUniversity,DepartmentofInternalMedicine,Sectionof Endocrinology;NewHaven,CTwitha3hrOGTT.Subjectswerefastedfrom8pm thenightpriortotesting.twentyminutesafterinsertionofanantecubitalivline, fastingbloodsampleswerecollectedfordeterminationofplasmaglucose.the75g dextrosedrink(glucola;curtinmathesonscientific,houston,txwasthen
16 11 administered,andbloodsamplescollectedat10,20,30,60,90,120,150,and180 minfordeterminationofplasmaglucoseandinsulinconcentrations.theinsulin SensitivityIndex(ISIwasusedtoestimateinsulinsensitivity(Petersenetal., 2006.PlasmaglucoseconcentrationsduringtheOGTTweremeasuredusingaYSI STAT2700Analyzer(YellowSpringsInstrumentCo.,YellowSprings,CA.Insulin concentrationsweremeasuredusingalincoriakit(emdmillipore;billerica, Massachusetts. Lipid&panel.Totalcholesterol,highdensitylipoprotein(HDL,andtriglycerides(TG concentrationsweremeasuredonanaceclinicalchemistrysystemautoanalyzer (AlfaWassermann;WestCaldwell,NJ.Lowdensitylipoprotein(LDL concentrationswerecalculatedfromtc,hdl,andtgwiththefriedewaldformula (Friedewald,Levy,&Fredrickson, H&MRS&Assessment&of&Intramyocellular,&Extramyocellular,&and&Hepatic&Lipid&Content.&& Intramyocellular(IMCLandextramyocellular(EMCLandhepaticlipidcontents weremeasuredusing 1 HMRSalsoincollaborationwithDr.KittFalkPetersenas previouslydescribed(petersenetal.,2006.musclelipidcontentwasmeasuredin thesoleusmuscleusingan8.5cmdiametercircular 13 Csurfacecoilwithtwin, orthogonalcircular13cm 1 Hquadraturecoils.Theprobewastunedandmatched andscoutimagesofthelowerlegwereobtainedtoensurecorrectpositioningofthe subjectandtodefineanadequatevolumeforlocalizedshimmingusingthe FASTMAPprocedure(Gruetter,1993.TheliverTGcontentwasmeasureby 1 H
17 12 respiratorygatedsteamspectroscopyina15x15x15mm 3 voxel.acquisitionwas synchronizedtotherespiratorycycleandtriggeredattheendofexpiration.a watersuppressedlipidspectrumandalipidsuppressedwaterspectrumwere acquiredinthreedifferentlocationsofthelivertoaccountforliverinhomogeneity. Aminimumofsixspectrawasacquiredforeachsubjectandthetotallipidcontent wasaveragedandcalculated.inaddition,hepaticlipidcontentwascorrectedfor transverserelaxation,usingthetransverserelaxationtimesof22msforwaterand 44msforlipid,aspreviouslydescribed(Rabol,Petersen,Dufour,Flannery,& Shulman,2011.& & IIIn#vitrostudies Theauthorofthisthesisdesignedandconductedallthein&vitroexperiments describedhere,unlessotherwisespecified. Materials.RecombinantmurineWnt3aandhumanWnt3awerepurchasedfrom R&DSystems(Minneapolis,MN.Referencesto Wnt intheseexperimentswillonly refertownt3ause.insulinhumalognd1048wasfromelilillyandcompany (Indianapolis,IN.GlucagonanddexamethasonewerepurchasedfromSigma Aldrich(St.Louis,MO.DMEM,heatinactivatedfetalbovineserum(FBS,andOpti MEMGlutaMAXwereallpurchasedfromGibcoLifeTechnologies(Carlsbad,CA.All reagentsusedforins1cellcultureswerepurchasedfromsigmaaldrich(st.louis, MOunlessotherwisespecified.
18 13 Cells.PrimaryhepatocytesisolatedfromSpragueDawley(SDratswerepurchased fromlifetechnologies(carlsbad,ca.hepg2cells(p76werepurchasedfrom AmericanTypeCultureCollection(ATCC;Manassas,VA.ExpressionlevelsofLRP5 transcriptsweremeasuredintissuesisolatedfromsdratpurchasedfromcharles River(Wilmington,MA.TheINS1832/13ratinsulinomacelllinewasgenerously providedbydr.richardkibbey(yaleuniversity;newhaven,ct,andinitialstocks wereoriginallyreceivedfromchristophernewgard(dukeuniversity;durham, NorthCarolina(Hohmeieretal.,2000. Primary&Rat&Islets.SpragueDawleyratpancreaticisletswerepreparedbyTamara DlugosintheYaleDiabetesEndocrinologyResearchCenter. Primary&Hepatocyte&Cell&Cultures.Pelletedcellswereresuspendedtwiceinmedia containinghighglucosedmem,10%fbs,1nmdexamethasone,1nminsulin,and P/S(1:100.Cellswereplatedataninitialdensityof5x10 5 incollagencoated6well platesandincubatedforfourhoursat37 C.Cellswerethenwashed1xwith phosphatebufferedsaline(pbsandincubatedat37 CovernightinOptiMEM GlutaMAX.Thenextmorningcellswerewashed1xwithPBSandincubatedfortwo hoursinglucosefreedmemcontainingsodiumbicarbonate.cellswerewashed againwithpbs,andthenreceivedoneofthefollowingtreatmentsinglucosefree, bicarbonatefreedmem: nMdexamethasone nMglucagonwith1mMsodiumpyruvate
19 nMinsulin,Wnt(100ng/mL 4. Wntanddexamethasone 5. Wntandglucagonwith1mMsodiumpyruvate 6. dexamethasoneandinsulin 7. glucagonandinsulin Mediawassampledat1,3,5,12,and24hrsaftertreatmentwasinitiated.The24 hourtimepointdatawereusedfortheanalysesreportedhere.cellswerewashed withpbsandrnaextractedusingtherneasykit(qiagen,valencia,ca. HepG2&Cell&culture.CellswerethawedandcentrifugedaccordingtotheATCC recommendedprotocol.theywerethentreatedwiththesamereagentsunder identicalconditionsasdescribedaboveinthesectiononprimaryhepatocytecell Cultures. INS51&Cell&Culture.ThisexperimentwasperformedincollaborationwithDr.Richard Kibbey(YaleUniversity;NewHaven,CTandRebeccaPongratzfromhislaboratory. INS1&cellsweremaintainedasmonolayersinRPMI1640completemediumwith 11.1mMDglucosesupplementedwith10%(v/vfetalbovineserum,antibiotics (10,000units/mlpenicillinand10mg/mlstreptomycin,10mMHEPES,4mML glutamine,1mmsodiumpyruvate,and50mmbetamercaptoethanol.for experiments,cellswereplatedinto6wellplatesatadensityof2.0x10 5 cellsper wellandculturedat37 Cuntil80%confluent.Cellswerethenrandomlyassignedto
20 15 threeconditions:wntpretreatment,nowntpretreatment,ornownttreatment.for pretreatmentwnt(100ng/mlwasaddedthenightpriortoglucosestimulation. EquivalentamountsofPBSwereaddedtothenonpretreatmentcellstoensure equivalentvolumesofmedia.onthedayoftreatmentcellswerewashedwithpbs andthenpreincubatedinbasalmediafor90minutes.basalmediawasglucosefree DMEMcontaining3.7g/LNaHCO3,4mMglutamine,10mMHEPES,2.5mMdextrose and0.2%96%fattyacidfreebovineserumalbumin.wntwasaddedtothemediaof cellsselectedforwnttreatment.mediawasthenchangedtobasalmediacontaining either2.5mmdextrose±wnt,orstimulationmediacontaining9mmdextrose±wnt for45minutes.followingtheincubation,mediafractionswerecollectedandplaced oniceuntilanalyzedforinsulincontent.theremainingmediawasaspirated,cells werewashedwithpbsx2andthen1mloficecold0.1%tritonx100wasadded. Celllysateswerecollectedandassayedforprotein. INS51&insulin&analysis.Insulinconcentrationintheconditionedmediawasmeasured usingthehighrangeratinsulinelisakitin96wellplates(alpcodiagnostics, Salem,NH.Allmediaextractswerenormalizedtoacellproteinconcentrationusing amicrobcaproteinassaykit(thermoscientific;waltham,maandthe manufacturer srecommendedprotocol. Human&islet&perfusion.ThisexperimentwasalsoperformedincollaborationwithDr. KibbeyandMs.Pongratz.HumanisletswereobtainedfromtheUniversityofAlberta IsletCore,AlbertaDiabetesInstitute,Edmonton(Pigeauetal.,2009.Isletswere
21 16 culturedincompletecmrlmediaat37 Cwith5%CO2,95%airuntilthetimeof theexperiment.priortoperfusion,approximately160islets(40islets/per replicatewerepretreatedwithwnt(75ng/mlfor19hours.another160islets weredesignatedasthecontrol(nowntpretreatment.isletswereperfusedwith DMEMbasalmediacontaining2.5mMglucose(D5030,Sigma.Fortyisletsper chamberwereperifusedwithbasalmediafor45minutestoequilibratetheisletsto thecolumnandinstrument.afterthepreincubation,isletswereperifusedwiththe differenttreatmentsand100ulofperifusatecollectedperminute.theperifusion protocolconsistedofabasalperiodof2.5mmglucosefor20mininwhichwnt (75ng/mLwasaddedbacktothetreatmentgroupisletsafter10minand maintainedforthedurationoftheperifusion.thebasalperiodwasfollowedbya 9mMglucosestimulationfor45min.Theglucoseconcentrationwasthenreducedto 2.5mMglucosefor15minfollowedbyasecondstimulationwith30mMKClat 2.5mMglucose(5min.toevaluateinsulinsecretionindependentofglucose metabolism.theisletswerethenallowedtorecoverinbasalmediafor5min. InsulinlevelsintheperfustateweremeasuredwithanELISAforhumaninsulin(80 INSHUE01,ALPCODiagnostics,Salem,NHandnormalizedtotheDNAcontentof thecelllayer(p7589,molecularprobes. Quantitative&Real&Time&PCR.TotalRNAwasisolatedusinganRNeasykit(Qiagen, Valencia,CAperthemanufacturersinstructions.cDNAsynthesiswascarriedoutat 43 Cfor45minfollowedbydenaturationat95 CforfiveminutesusingacDNA synthesiskit(stratagene,lajolla,ca.quantitativerealtimepcr(qpcrwas
22 17 performedwithtaqmanpcrreagentkits(stratagene,lajolla,causing40ngof RNAwithareactionvolumeof20uLusingtheOpticon2DNAEngineContinuous FluorescenceDetectionSystem(MJR,Waltham,MA.Specificprimer/probesetsfor targetgeneswerepurchasedfromappliedbiosystemslifetechnologies(carlsbad, CA(seeTable1.AllqPCRreactionswereperformedinduplicate,andcycling conditionswere95 Cfor20sand60 Cfor1minfor39cycles.Theamplification signalfromthetargetgenewasnormalizedtoabeta5glucuronidasesignalinthe samereaction.therelativeexpressionlevelsweredeterminedusingthe comparativectmethod(alsoknownasthe2ctmethod.dataarepresentedasthe relativemrnalevels. Statistical&Analyses.Weestimatedwecouldrecruit11subjectsfromtheaffected kindredssuitableforanalysistobepairedwith22matchedcontrolsina2:1ratio. Basedonpreliminarycontroldata,weestimatedthatthestandarddeviation(SD forhba1cwouldbe0.22(%.sincewedidnotknow,a&priori,whatthesdwouldbe forhba1cintheaffectedindividualsweconservativelyestimateditat0.44(%. UsingtheseestimatesforSDs,wewouldhave99%powertoseeadifferencein HbA1cvaluesof0.5%orgreater,and80%powertoseeadifferenceof0.3%or greater(graphpadstatmate2.0:graphpadsoftwareinc.,lajolla,ca. StatisticaldifferenceswereanalyzedusingtheunpairedStudentttest,andoneway ANOVAwhereappropriate(GraphPadPrismversion6.00forWindows,GraphPad Software;LaJollaCaliforniaUSA,
23 18 ±standarderrorofthemean(sem.differenceswereconsideredstatistically significantwhenp<0.05. RESULTS IHumanStudies Baselinecharacteristicsoftheaffectedsubjectsandtheage,gender,andBMI matchedcontrolgroupareshownintable2.meanbmiofthesegroupswere 27.4±1.8and27.6±1.1,respectively. HbA1c&is¬&significantly&different&in&individuals&with&HBM&mutations&in&LRP5&& Theparametersofglucosemetabolismmeasuredinthestudysubjectsare presentedintable3.twoaffectedsubjectswereknowndiabeticstakinginsulin. Thesesubjectsandtheirfourmatchedcontrolswereexcludedfromanalysis.With9 affectedindividualsand18controls,wehad99%powertoseea1.0%difference and80%powertoseea0.6%differenceinhba1cvalues.changesofthismagnitude wouldhavebeenclinicallymeaningful.however,wedidnotobserveanydifference inthisparameter.&therewerenostatisticallysignificantdifferencesbetween affectedandcontrolpopulationsforhba1c(p=0.06,eag(p=0.06,insulin(p=0.82, HOMAB(p=0.34andHOMAIR(p=0.66.MeanHbA1cforaffectedandcontrol groupswere5.8±0.3%and5.4±0.5%respectively.oneaffectedsubjectandone controlsubjectwerefoundtohaveelevatedhba1clevelsinthediabeticrange ( 6.5whentestedforthepurposesofthisstudy.HbA1cvaluesaredepictedin Figure2.&
24 19 OGTT&results&were¬&significantly&different&in&individuals&with&HBM&LRP5&mutations&& ThreesubjectswiththeHBMLRP5mutationunderwentanOGTT.Bloodglucose (Fig.3A,insulin(Fig.3Bandcpeptide(Fig.3Clevelswerenotconsistently differentfromthecontrolgroup,suggestingthatthereisnodifferenceininsulin productionaswellasininsulinsensitivityinthesethreeindividualswhen comparedtoalargecontrolgroup. IMCL&and&liver&TG&is¬&significantly&different&in&individuals&with&HBM&mutations&in& LRP5& AspartoftheplannedinvestigationintotheroleofLRP5inglucosemetabolism,we alsomeasuredintramyocytelipidasanindexofinsulinsensitivity.inparticular, thereisasubstantialliteratureonassessingintramyocellularlipid(imclcontent asabiomarkerofinsulinsensitivity:magneticresonancespectroscopy(mrs studiesindiabeticandnondiabeticpatientshaveshownthatinsulinresistancecan beattributedtopostreceptordefectsininsulinsignaling,forexample,reduced Glut4transporteractivitycausedbymetabolitesofintracellularlipids(Morino, Petersen,&Shulman,2006;Petersenetal.,2007.Studiesinahealthy,leanelderly individuals,leanandobeseadolescents,andlean,insulinresistantoffspringof patientswithtype2diabetes(petersenetal.,2003;petersen,dufour,befroy,garcia, &Shulman,2004;Sinhaetal.,2002,allsupporttheconclusionthatinsulin resistanceresultsfromtheintracellularaccumulationoffattyacylcoas,and diacylglycerolinskeletalmyocytesandhepatocytes.theseadverseeffectscanbe attenuatedwithweightloss(petersenetal.,2005;petersenetal.,2012;raboletal.,
25 TwooftheLRP5affectedsubjectsunderwentMRSoftheirskeletalmuscleandliver (Table4.TheInsulinSensitivityIndex(ISIwaspredictablyhigherinSubjectBwho hadalowerbmi,lowerpercentbodyfat,andhigheractivitylevel(notshownthan SubjectA.TheISIofbothsubjectscomparedtothecontrolgroupsvariespredictably withbmiandbodyfatpercentage,withsubjectahavingalowerpercentbodyfat andhigherisicomparedwithcontrols,andsubjectbhavingahigherbmiandlower ISIcomparedwithcontrols.TheIMCLinbothsubjectswasnotsignificantlydifferent comparedtothecontrolgroup.therewasalsonoconsistenttrendinlivertg towardshigherorlowerpercentagelipidscomparedwithcontrols. LDL&cholesterol&levels&are&lower&in&affected&study&subjects& LipidprofilesfortheaffectedindividualsarepresentedinTable5.Threeaffected andtwocontrolsubjectswereknowntohavehypercholesterolemiaandwere takingcholesterolcontrollingmedicationsatthetimeofstudy.thesesubjects,and theirmatchedcontrols,wereexcludedfromtheanalysis. Therewerenosignificantdifferencesintotalcholesterol,TGs,andHDL,between controlandaffectedsubjects(figs.4ac.howeverasshowninfigure4d,ldl levelsweresignificantlylowerinaffectedsubjects(p=0.04.
26 21 IIIn#vitrostudies Tissue&survey& AsaninitialsteptoexploretheroleofWntsignalinginglucosemetabolism,we surveyedtheexpressionoflrp5inseveraltissuesinvolvedinfuelmetabolism. LRP5expressionwashighestinliver,andlowestinbone(Fig.5.&Thesedatalargely agreewithpreviouslypublishedtissueexpressionsurveysoflrp5(heyetal., 1998.& Testing&the&hypothesis&that&Wnt&suppresses&gluconeogenesis&by&inhibiting&PEPCK5C& HBMmutationsinLRP5arepositedtoexerttheireffectontheskeletonbycausinga functionalincreaseinwntsignaling.thisisnotduetoligandindependentreceptor signaling,butratherduetoaresistanceofthesemutantreceptorstoendogenous inhibitorssuchasdkk1.thus,invivo,thesemutantreceptorstransmitagreater signalinthepresenceofendogenousinhibitorsthanthewildtypereceptor.froma functionalstandpoint,therefore,thesemutationsconstitutegainoffunctioninwnt signaling.wethereforesoughttodeterminetheeffectofwntsignalingonglucose metabolismbytestingtwohypotheses. ThefirstwasthatWntsignalingwouldsuppressgluconeogenesisbyinhibitingone ofthekeyenzymesinthegluconeogenicpathway,thecytosolicformof phosphoenolpyruvatecarboxykinase(pepckc.pepckccatalyzesthefirst committedstepofgluconeogenesis,specificallytheconversionofoxaloacetate+gtp >phosphoenolypyruvate+gdp+c02.itisnotregulatedposttranslationallyor
27 22 allostericallybutentirelytranscriptionallysuchthatenzymeactivityisdirectly proportionaltotheleveloftranscriptexpressedintheliver.(chakravarty,cassuto, Reshef,&Hanson,2005.Previousworkinprimaryhepatocytes,hepatomacell lines,andanimalmodelshasexploredtheeffectofcanonicalwntsignalingon PEPCKCandmodulationofthegluconeogenicresponse(Hall,Wang,George,Koch, &Granner,2007;Liuetal.,2011.WhilethePEPCKpromoterhasnoknown canonicalwntbindingmotifs,pepckcisinhibitedbyglucagonsynthasekinase3 (GSK3adownstreamtargetforcanonicalWntsignaling.ActivationofWntsignaling suppressesgsk3activity(frame&cohen,2001.thereforewehypothesizedthat Wntsignalingwouldsuppressgluconeogenesis,byinhibitingPEPCKCexpression. Wnt&does¬&effect&PEPCK5C&expression&in&primary&hepatocytes& AsdepictedinFigures6AC,andasexpected,PEPCKexpressioninprimary hepatocyteswassuppressedbyinsulin,andinducedbydexamethasoneand glucagon.pepckinductionbyglucagonwasbluntedbyinsulin.theseareallknown effectsofinsulin,dexamethasoneandglucagonandconfirmthatourin&vitroassayis sensitiveenoughtodetectchangesinducedbyhormonesandcytokines.however, theadditionofwntdidnothaveasignificantsuppressiveeffectonpepckc expressionascomparedtothecontrol(fig.7anordiditblunttheeffectof glucagon(fig.7c.unexpectedly,wntseemedtoenhancetheeffectof dexamethasonethoughthechangewasnotstatisticallysignificant(fig.7b.these resultswereconfirmedinexperimentsunderthesameconditionsusingcellsfrom thehepg2cellline.
28 23 Testing&the&hypothesis&that&Wnt&augments&glucose5stimulated&insulin&secretion&in& pancreatic&islets& TheeffectofWntoninsulinreleasefrompancreaticisletbeta5cellswasalso exploredasanalternativemechanismbywhichwntsignalingcouldaffectglucose metabolism.asnotedearlier,wntfailstostimulateinsulinsecretionfromislets isolatedfromlpr5knockoutmice;conversely,exposureofwildtypeisletstownt stimulatedglucoseinducedinsulinsecretion(fujinoetal.,2003. WeinitiallyundertookstudiesusingtheINS1832/23celllinesincethesecellshave importantsimilaritiestopancreaticbetacellsincludingthoserelatedtoinsulin secretion(cline,lepine,papas,kibbey,&shulman,2004;hohmeieretal.,2000;lu etal.,2002;pongratz,kibbey,shulman,&cline,2007.thereforeweexpectedthat theresultsinthesecellswouldlikelymirrorthoseinprimaryhumanislets. Wnt&does¬&augment&glucose5stimulated&insulin&secretion&in&INS51&cells& 9.0mMglucosestimulatedinsulinsecretioninINS1celltwofoldcomparedtothe secretoryrateunderbasalconditions(2.5mmglucose.addingwnttoeitherbasal ortostimulatoryglucoseconcentrationshadnostatisticallysignificanteffecton insulinsecretion(fig.8. GivenpriorreportsthatWntisactiveinpancreaticbetacellswenextsoughtto confirmlrp5expressionintheins1832/23cells.forthesestudiesthelevelof LRP5transcriptexpressionintheINS1832/23cellswascomparedtothatin
29 24 primaryratislets.lrp5expressionissignificantlylowerintheins1832/23cells whencomparedtotheprimarycells(fig.9.thissuggeststhatwntdoesnotaffect insulinsecretioninins1832/23cellsperhapsinpartbecausethelevelofreceptor expressionistoolow.& Wnt&does¬&augment&glucose5stimulated&insulin&secretion&in&primary&human&islets& InviewofthefindingthatLRP5wasonlyexpressedatalowlevelinINS1832/23 cells,wenextexaminedtheeffectofwntoninsulinsectioninprimaryhumanislets. HumanisletsareknowntohaverobustexpressionofLRP5(Heyetal.,1998.That notwithstanding,glucoseinducedinsulinsecretioninprimaryhumanisletswasnot affectedbywnt(fig.10.whilethesedataareconsistentwithourfindinginthe INS1cells,theyareatvariancewithpriorstudiesusingmurineisletsinwhichWnt treatmentledtoadoublingofglucoseinducedinsulinsecretion(fujinoetal.,2003. DISCUSSION Theprevalenceandreachofdiabetesacrossgenerationsandpopulationsiswell known.overeightpercentoftheunitedstatespopulationhasdiabetes.in particular,thereisanincreasedincidenceamongadolescentandnonwhite populations( healthsystemsfacesoaringdirectmedicalcosts,whichtopped$176billionin2012. Theaverageannualcostofcaringforadiabeticis2.3timeshigherthananon diabetic,multiplyingthecostofthediseaseacrosshospitalizationsandoutpatient visits("economiccostsofdiabetesintheu.s.in2012,"2013.notably,these
30 25 estimatesdonotaccountfortheadditional,significantcostofreducedproductivity andcaregiverburden. WntsignalingthroughLRP5representsanewlyappreciatedmetabolicpathwaythat mightbeatargetfordrugdiscoveryintype2diabetes.inpreadipocyteswntand insulinsignalinghavebeenshowntointeractwithlrp5exertingapositiveeffecton insulinsignaling(palsgaardetal.,2012.studiesinrodentssupporttheconclusion thatlrp5mediatesglucoseandlipidmetabolism(fujinoetal.,2003;magoorietal., 2003.However,datafromhumanstudiesinLBMcausingmutationspopulations hasnotbeenasconsistent,withsomestudiessuggestingthattheseindividualshave impairedglucosemetabolismandothersfailingtofindasimilartrend(saarinenet al.,2010;zenibayashietal.,2008. Inviewoftheseconflictingdataandbecauseavarietyofmethodologieshavebeen usedtomeasureglucoseandlipidmetabolismwerevisitedtherelationshipsina humanpopulationthathasnotyetbeenstudied:thosewithhbmcausingmutant LRP5receptors. Ourdatashowthatcomparedtomatchedcontrols,individualswithHBMcausing LRP5mutationsdidnotdemonstrateimprovedglucosehomeostasis.HbA1c,a commonclinicaltestfordiagnosisandclinicalmonitoringofdiabetes,wasnot significantlydifferentbetweencontrolandaffectedpopulations.similarly,therewas nodifferenceineag,insulinlevels,homab,andhomairscores.asnoted,our
31 26 studyincludedmembersofmultiplekindreds,encompassingtwodifferenthbm causingmutationsinlrp5.whilethestudywassufficientlypoweredtodetecta differenceinhba1cbetweenthetwostudygroups,itwasnotpossibletodoa meaningfulsubanalysisofthesmallnumberofindividualswiththen198s mutationtodetermineiftheirresponsedifferedfromthatintheindividualswith theg171vmutations.however,asubanalysisofg171vmutationkindredmembers alonealsodemonstratednosignificantdifferencefromthecontrolgroup(p=0.07 (datanotshown.inotherstudiesinthesekindredsithasbeensuggestedthatthein vivoactionsofthesetwomutationdiffered(leeetal.,2013. AsmallersampleofaffectedLRP5subjectsunderwentanOGTTandMRSofliver andskeletalmuscle.inagreementwiththedatainthelargerstudygroup,blood glucose,insulinlevels,andcpeptidelevelswerenodifferentinthesethree individualscomparedtocontrols.theisivariedappropriatelywithbmi,percent bodyfatandactivitylevel,andtherewasnotrendtoindicateimprovedinsulin sensitivityinthetwoaffectedindividualswhoparticipatedintheseanalyses. PreviousstudieshavefoundastrongrelationshipbetweenIMCLcontentand muscleinsulinresistance,suggestingthatintracellularlipidmetabolitesmightbea causalfactorinitspathogenesis.mrsmeasuresoftginmuscleandliverareuseful proxiesforassessingspecificfattyacidcontent(i.e.diacylglycerolsthatcould otherwiseonlybeevaluatedwithinvasivetechniquessuchasmusclebiopsy.we hypothesizedthatonemechanismbywhichlrp5affectedindividualscouldhave improvedglucosemetabolismwasthroughimprovedinsulinsensitivityresulting
32 27 fromreducedimclcontent.givenoursmallsamplesize,wewouldhaveneededto seeaveryrobustdifferencebetweenthefindingsinthetwostudysubjectsandthe entirecontrolgroup.however,insulinsensitivityinthesetwostudysubjectswasno differentfromthatofthecontrolsubjects.itisworthrecallingthattwoaffected subjectsweretakinginsulinandwereexcludedfromtheseanalyses.athirdaffected subjectwasfoundtohaveaserumhba1cinthediabeticrange.theseobservations supportthefindingsthathbmcausingmutationsdonotimpactglucose homeostasis.consistentwiththat,ourdataalsoindicatethathbmcausinglrp5 mutationsdonotimproveinsulinsensitivityorinsulinproduction.iflrp5playsa roleinglucosehomeostasis,thenthisstudysuggeststhatitsimpactisminimalin comparisontomoredominantfactorsthuskeepingusfromobservingitinasmall population. Inadditiontoeffectsonglucosehomeostasis,animalstudiesalsopointtoarolefor LRP5inlipidhomeostasis.LRP5 / micefedhighfatdietshadelevatedcholesterol, andimpairedplasmaclearanceofdietderivedtriglyceridesimplyingapossible ApoEindependentroleforLRP5intriglyceridehydrolysis(Magoorietal.,2003. However,studiesinhumanLBMcausingmutationpopulations,havenotfound differencesinlipidlevels.ofnote,thesestudieswerenotcontrolmatched,andone studyincludedmultiplesubjectsonlipidloweringdrugs.(saarinenetal.,2010; Zenibayashietal.,2008. Ouranalysisexcludedindividualsonlipidloweringdrugsandcontrolledforgender, age,andbmi.totalcholesterol,triglyceridesandhdlwerenotdifferentbetween
33 28 affectedandcontrolspopulations.however,ldlwassignificantlylowerinthe affectedsubjects.thisfindingisparticularlyinterestingasthelrp5receptoris knowntobindapoecontaininglipoproteinsin&vitro&(kimetal.,1998. LRP5isknowntobehighlyexpressedintheliverandinhepatocytes(Heyetal., 1998;Kimetal.,1998.Weconfirmedthisinthecurrentstudy.Wehypothesized thattheadditionofwntwouldinhibitpepckc,aratelimitingstepinthe gluconeogenicpathway.sinceacceleratedgluconeogenesisplaysanimportantrole intype2diabetes,thishypothesishadconsiderableclinicalrelevance.howeverour in&vitro&studiesconsistentlyshowednoeffectwntonpepckcinprimary hepatocytes.neithertheinductionofpepckbydexamethasoneorglucagonorthe suppressionbyinsulinwasaffectedbywnt.itremainspossiblethatwntsignaling throughlrp5hastargetsgenesotherthanpepcktomodulategluconeogenesis, thatwerenotconsideredinthecurrentstudy. WealsoexaminedtheeffectofWnttreatmentinINS1cellsandhumanisletsto assesstheimpactthishasoninsulinsecretion.ratins1cells,consideredavalid systemtostudyinsulinsecretiondynamics(hohmeieretal.,2000,responded appropriatelytoglucosestimulationwitharobustincreaseininsulinsecretion. However,theydidnotfurtherincreaseinsulinproductioninresponsetoWnt treatment.sincethesecellshadlowlevelsoflrp5comparedwithprimaryratislets, thesestudieswereextendedtohumanislets.wnttreatmentfor16hoursdidnot changehumaninsulinproductionunderbasalorglucosestimulatedculture
34 29 conditions.thesefindingsareatoddswiththefindingthatwntincreasedglucose inducedinsulinsecretioninmurineislets(fujinoetal.,2003.thereasonforthese divergentfindingsisnotclear.oneobviouspossibilityisthatmurineandhuman isletsresponddifferentlytownt.whythendoesmurineboneapparentlyfaithfully recapitulatetheeffectsofwntonthehumanskeleton?thismaybebecausethe macroarchitectureofboneaswellastheinteractionsofbonecellsareverysimilar inmouseandman.incontrast,thearchitectureofthemurineisletaswellasits cellularcompositionisdifferentfromthehumanislet(steineretal.,2010,andso maybethebiologicalmechanisminvolvedinthedevelopmentandmaintenanceof thesetissues. Conclusion& StudiesofLBMcausingmutationsinLRP5inbothexperimentalmodelsandin humanswithoppgsuggestthatlossoffunctioninthisreceptorisassociatedwith impairedglucosetolerance.howeverthesestudiesarelimitedbythelackofcontrol groupsandsmallnumbersofsubjectsstudied.ourstudy,thefirstinhumanswith HBMcausingmutationsinLRP5,includedacarefullymatchedcontrolgroupanda largernumberofaffectedindividuals.thesefindingsprovidestrongevidencefora limitedroleoflrp5inglucosemetabolismaswecouldnotdemonstratean interactionbetweenthetwo. TheHBMcausingmutationsstudiedinourkindredsarenottissuespecificintheir actions(asdemonstratedbyourexpressionsurvey,andshouldchangewnt
35 30 signalinganywherethatwntacts.ourstudypopulationincludedtwohbmcausing mutations,eachwithextremeskeletalphenotypes.giventherobustphenotypein bone,weanticipatedaconsiderablephenotypeinglucosehomeostasis.although thesamplesizefortheogttandmrssubanalysesweretoosmalltodemonstrate statisticalsignificance,wecouldidentifynotrendtowardincreasedinsulin sensitivityoralteredinsulinproduction.infact,threeofthekindredmembers screenedforinclusioninthisstudyhaddiabetesand/orinsulinresistance.these resultsareindirectcontradictiontothefindingsinpreviouslyreportedanimal models,underscoringthepotentiallimitationsinextendingsomefindingsinmiceto humans. Whileourfindingsdonotdirectlyevaluatetheroleoflossoffunctionmutationsin LRP5onglucosemetabolism,theydomakeLRP5alessattractivetargetfordrug discoveryindiabetes.however,itdoesappearthatthereisaneffectonldl metabolism,amajorriskfactorforcoronaryarterydisease.todetectastatistically significanteffectonldlevenwithoursmallsample,certainlysuggeststhatthe molecularmechanismunderpinningthiseffectwarrantsfurtherstudy. Insummary,ourdatadoesnotsupportthehypothesisthatLRP5improvesglucose metabolisminindividualswithhbmcausinglrp5mutations.thedatasuggestthat theremaybeaspecific,beneficialeffectoflrp5onldlcholesterol.additional studiesshouldfocusonclarifyingthecellularandmolecularmechanismsbywhich theseoccur.
36 31 FIGURES&TABLES Figure1A.G171VKindredPedigreeofFamilyA Affectedkindredmembers,indicatedbydarksymbols,haveasinglebasepair mutationcausingaglycinetovalinechangeatposition171inthelowdensity lipoproteinrelatedreceptorprotein5(lrp5.thisresultsinahighbonemass (HBMphenotype. Figure1B.G171VKindredPedigreeofFamilyB Affectedkindredmembers,indicatedbydarksymbols,haveasinglebasepair mutationcausingaglycinetovalinechangeatposition171inthelowdensity lipoproteinrelatedreceptorprotein5(lrp5.thisresultsinahighbonemass (HBMphenotype.
37 32 Table1.TaqManassaysusedforqPCRreactions. GeneSymbol NCBIgenereference TaqManassayID Pck1 NM_ Rn Alp1 NM_ Rn LRP5 NM_ Rn Actb NM_ Rn QPCRwasusedtoanalyzePEPCKCmRNAexpressioninexperimentsusingRNA fromprimaryhepatocytesandhepg2cells.lrp5mrnaexpressionwasanalyzedin avarietyofrattissues,ins1cells,andprimaryratislets. Table2.Baselinecharacteristicsofallstudyparticipants Variable Affected MatchedControls pvalue (n=11 (n=22 Age(years 63±7 63± Male(n,% 9(82% 18(82% n/a Female(n,% 2(18% 4(18% n/a BMI(kg/m ± ± Theterm affected referstothosestudysubjectswiththehbmcausinglrp5 mutations.therewerenostatisticaldifferencesinageandbmibetweenthetwo groups.therewereequivalentnumbersofmalesandfemalesenrolledinboth groups.thistabledemonstratesthatthecontrolgroupwasappropriatelymatched forthesecharacteristicstotheaffectedindividuals.dataisshownasmean±sem.
38 33 Table3.Measurementsofglucosemetabolisminaffectedstudyparticipants Pt# LRP5 BMI HbA1c eag A Insulin HOMA B [ HOMA[B genotype (kg/m 2 (% (uu/ml IR 1* g171v g171v g171v g171v g171v g171v g171v g171v * g171v n198s n198s Mean±SEM& 27.4±1.8& 6.0±0.3& 124.7±7.6& 11.7±1.7& 3.6±0.6& 74.7±13.0& AEstimatedaverageglucose=28.7xHbA1c46.7(Nathanetal.,2008 BHomeostaticModelAssessment *Subjecttakesinsulin Thistablesummarizestheresultsofthestudiesofglucosemetabolisminthe affectedindividuals.twosubjectsusinginsulinwereexcludedfromsubsequent analysis.
39 34 Figure2.HbA1cresultsinstudyparticipants HbA1cvaluesarenotsignificantlydifferentbetweenLRP5affectedindividualsand age,gender,andbmimatchedcontrols(p=0.06.errorbarsrepresentthestandard errorofthemean. Figure3A.ChangesinbloodglucoseduringtheOGTTinthreestudy participants ThreeaffectedsubjectsunderwentanOGTT.Therewasnoconsistentdifferencein glucoselevelsinthesethreeindividualscomparedtoagroupofpreviouslystudied age,race,bmi,andactivitymatchedcontrols(n=54.thetestingandcontroldata weregenerouslyprovidedbydr.kittfalkpetersen.
40 35 Figure3B.ChangesininsulinlevelsduringtheOGTTinthreestudy participants ThreeaffectedsubjectsunderwentanOGTT.Therewasnoconsistentdifferencein insulinlevelsinthesethreeindividualscomparedtoagroupofpreviouslystudied age,race,bmi,andactivitymatchedcontrols(n=54.thetestingandcontroldata werekindlyprovidedbydr.kittfalkpetersen.subjectbhasmoreintramyocyte lipidandislikelysomewhatinsulinresistant(seetable4. Figure3C.ChangesinC[peptidelevelsduringtheOGTTinthreestudy participants ThreeaffectedsubjectsunderwentanOGTT.Therewasnoconsistentdifferencein cpeptidelevelsinthesethreeindividualscomparedtoagroupofpreviously studiedage,race,bmi,andactivitymatchedcontrols(n=54.thetestingand controldatawaskindlyprovidedbydr.kittfalkpetersen.
41 36 Table4.Intramyocellularlipidandhepaticlipidtriglyceridecontentby 1 HMRS Subject BMI (kg/m 2 BodyFat(% ISI IMCL(% LiverTG(% SubjectA SubjectB Control(n= ± ± ± ± ±0.3 & Twoaffectedsubjectsunderwent 1 HMRSofskeletalmuscleandliverforlipid content.subjectswerecomparedtoacontrolgroup(n=54matchedforage,race, BMI,andactivitylevel.Whilethesampleistoosmallforstatisticalanalysis,there wasnotrendobservedinthedatatowardshigherorlowerpercentlipidcontent, whichhasbeenshowntobeanimportantmarkerofinsulinresistance(petersenet al., HMRStestingwasgenerouslyconductedbyDr.KittFalkPetersen.Data isshownasmean±sem. Table5.Lipidlevelsinaffectedindividuals Pt# A,B BMI (kg/m 2 Total Cholesterol (mg/dl TG (mg/dl HDL (mg/dl LDL (mg/dl Mean±SEM& 26.9±2.2& 169.5±11.8& 92.9±12.9& 64.0±7.2& 86.9±6.4& AGenotypesaslistedinTable3. BStudysubjects#1,#3,#5wereexcludedforreasonsdescribedintext. CLDL=TCHDL(TG/5(Friedewaldetal.,1972.
42 37 Figure4A.Comparisonoftotalbloodcholesterolinaffectedandcontrol individuals Individualstakinglipidloweringdrugswereexcludedfromtheanalysis.Total cholesterollevelswerenotsignificantlydifferent(p=0.43.dataisshownas mean±sem. Figure4B.Comparisonofbloodtriglyceridelevelsinaffectedandcontrol individuals Individualstakinglipidloweringdrugswereexcludedfromtheanalysis. Triglyceridelevelswerenotsignificantlydifferent(p=0.56.Dataisshownas mean±sem.
43 38 Figure4C.Comparisonofhighdensitylipoprotein(HDLlevelinaffectedand controlindividuals Individualstakinglipidloweringdrugswereexcludedfromtheanalysis..HDLlevels werenotsignificantlydifferent(p=0.32.dataisshownasmean±sem. Figure4D.Comparisonoflowdensitylipoprotein(LDLlevelsinaffectedand controlindividuals Individualstakinglipidloweringdrugswereexcludedfromtheanalysis.LDLlevels weresignificantlylowerinaffectedindividuals(p=0.04.dataisshownas mean±sem.
44 39 Figure5.RelativeexpressionofLRP5inrattissues LRP5expressionwashighestintheliver,andlowestinbone.Transcriptexpression isdefinedasfoldchangeincomparisontoliver. Figure6A.RegulationofPEPCK[Cexpressioninprimaryrathepatocytesby insulin Phosphoenolpyruvatecarboxykinase(cytosolicform(PEPCKCexpressionin primaryrathepatocyteswasmeasuredinthepresenceofknowninducersand inhibitorstoconfirmthesensitivityofourin&vitroassay.insulinpredictably suppressedpepckcexpressioncomparedtothecontrol(p=0.02.dataisshownas mean±sem.
45 40 Figure6B.RegulationofPEPCK[Cexpressioninprimaryrathepatocytesby dexamethasone PEPCKCexpressioninprimaryrathepatocyteswasmeasuredinthepresenceof knowninducersandinhibitorstoconfirmthesensitivityofourin&vitroassay. DexamethasonepredictablyinducedPEPCKCexpressioncomparedtothecontrol (p=0.05.dataisshownasmean±sem. Figure6C.RegulationofPEPCK[Cexpressioninprimaryrathepatocytesby glucagon,insulinanddexamethasone PEPCKCexpressioninprimaryrathepatocyteswasmeasuredinthepresenceof knowninducersandinhibitorstoconfirmthesensitivityofourin&vitroassay. GlucagonpredictablyinducedPEPCKCexpressioncomparedtothecontrol.This experimentconfirmedtheinductionofpepckcbydexamethasone,andits
46 41 suppressionbyinsulinrelativetocontrol.theeffectofglucagonwasbluntedby insulin(p=0.01.dataanalyzedusingonewayanova.dataisshownasmean±sem. Figure7A.EffectofWntonPEPCK[Cexpressioninprimaryrathepatocytes PEPCKClevelsweremeasuredaftertreatmentfor24hourswith100ng/mlofWnt. WnthadnoeffectonPEPCKCtranscriptexpression(p=0.42.Dataisshownas mean±sem. Figure7B.EffectofWntandDexamethasone[inducedexpressionofPEPCK[C inprimaryrathepatocytes PEPCKCtranscriptlevelsweremeasuredaftertreatmentwithWntorWntin combinationdexamethasone.dexamethasonealoneinducedpepckcexpression. TheadditionofWntdidnotsignificantlychangetheeffectofdexamethasone (p=0.42.dataisshownasmean±sem.
47 42 Figure7C.EffectofWntandglucagononPEPCK[Cexpressioninprimaryrat hepatocytes PEPCKClevelsweremeasuredinaftertreatmentwithWntorincombinationwith glucagon.glucagonaloneinducedpepckcexpression.theadditionofwntdidnot significantlyaltertheresponsetoglucagon(p=0.90.dataisshownasmean±sem. Figure8.TheeffectofWntonglucose[inducedinsulinsecretioninINS[1cells INS1cellsweretreatedwithWntinthepresenceofbasal(2.5mMandstimulatory (9.0mMlevelsofglucoseHighextracellularglucosesignificantlyincreasedinsulin secretion.however,theadditionofwntdidnotchangebasalorglucosestimulated insulinsecretion.dataisshownasmean±sem.
48 43 Figure9.LRP5transcriptexpressioninINS[1cellsandprimaryratislets. LRP5transcriptexpressionintheINS1cellswascomparedtothatinprimaryrat islets.lrp5expressioninins1cellswaslessthanhalfofthatintheprimaryrat islets. Figure10.EffectofWntonglucose[inducedinsulinreleasefromprimary humanislets HumanisletswereperifusedwithWntandexposedtobasal(2.5mMand stimulatory(9.0mmconcentrationsofglucose.glucoseinducedinsulinsecretion wasnotaffectedbywnttreatment.
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti
More informationCt=28.4 WAT 92.6% Hepatic CE (mg/g) P=3.6x10-08 Plasma Cholesterol (mg/dl)
a Control AAV mtm6sf-shrna8 Ct=4.3 Ct=8.4 Ct=8.8 Ct=8.9 Ct=.8 Ct=.5 Relative TM6SF mrna Level P=.5 X -5 b.5 Liver WAT Small intestine Relative TM6SF mrna Level..5 9.6% Control AAV mtm6sf-shrna mtm6sf-shrna6
More informationWhat is Diabetes Mellitus?
Normal Glucose Metabolism What is Diabetes Mellitus? When the amount of glucose in the blood increases, After a meal, it triggers the release of the hormone insulin from the pancreas. Insulin stimulates
More informationSupplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures
Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2
More informationSCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
More informationSYNOPSIS OF RESEARCH REPORT (PROTOCOL BC20779)
TITLE OF THE STUDY / REPORT No. / DATE OF REPORT INVESTIGATORS / CENTERS AND COUNTRIES Clinical Study Report Protocol BC20779: Multicenter, double-blind, randomized, placebo-controlled, dose ranging phase
More informationRisk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication
41 Research Article Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication Amarjeet Singh*, Sudeep bhardwaj, Ashutosh aggarwal Department of Pharmacology, Seth
More informationHOW TO DEFINE GOOD BIOMARKERS OF HEALTH? Suzan Wopereis
HOW TO DEFINE GOOD BIOMARKERS OF HEALTH? Suzan Wopereis My personal objective: identification of biomarkers of (optimal) health Biomarker Definition: a characteristic that is objectively measured and evaluated
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationFigure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
More informationLEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME
LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME Diana A. Chirinos, Ronald Goldberg, Elias Querales-Mago, Miriam Gutt, Judith R. McCalla, Marc Gellman and Neil Schneiderman
More informationSITA 100 mg (n = 378)
Supplementary Table 1. Summary of Sulfonylurea Background Therapy at Baseline and During the Treatment Period. Sulfonylurea at baseline, n (%) SITA 100 mg (n = 378) CANA 300 mg (n = 377) Total (N = 755)
More informationTable S2: Anthropometric, clinical, cardiovascular and appetite outcome changes over 8 weeks (baseline-week 8) by snack group
Table S1: Nutrient composition of cracker and almond snacks Cracker* Almond** Weight, g 77.5 g (5 sheets) 56.7 g (2 oz.) Energy, kcal 338 364 Carbohydrate, g (kcal) 62.5 12.6 Dietary fiber, g 2.5 8.1 Protein,
More informationDeprivation Study. The Freiburg Study
The Freiburg Study Deprivation Study Free Radicals Inflammation (hs-crp) Blood Pressure (Systolic, Diastolic) Blood Lipids (Cholesterol, Triglycerides) Energy Utilization (Heart Rate) Sugar Metabolism
More informationThe effect of cholesterol-related knowledge on patients' ability to reach target cholesterol levels
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 2003 The effect of cholesterol-related knowledge on patients' ability
More informationSupplementary Online Content
Supplementary Online Content Anagnostou E, Aman MG, Handen BL, et al. Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autistic spectrum disorder:
More informationSupplementary Table 1. The distribution of IFNL rs and rs and Hardy-Weinberg equilibrium Genotype Observed Expected X 2 P-value* CHC
Supplementary Table 1. The distribution of IFNL rs12979860 and rs8099917 and Hardy-Weinberg equilibrium Genotype Observed Expected X 2 P-value* CHC rs12979860 (n=3129) CC 1127 1145.8 CT 1533 1495.3 TT
More informationPredictors Of A Differential Neural Response To Infant Cues In Substance Using And Non-Using Mothers
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2012 Predictors Of A Differential Neural Response To Infant
More informationInsulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults
Insulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults Ochoa JE 1, Correa M 2, Valencia AM 2, Gallo J 2, McEwen
More informationSupplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
More informationSERUM VISFATIN LEVELS IN PATIENTS WITH SUBCLINICAL AND NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS
Acta Medica Mediterranea, 2017, 33: 197 SERUM VISFATIN LEVELS IN PATIENTS WITH SUBCLINICAL AND NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS ASLAN ÇELEBI * MUJGAN GURLER **, DENIZ ÖGÜTMEN KOC *, ALI ABBAS OZDEMIR
More informationSupplementary Figure 1. Blood glucose and insulin levels in mice during 4-day infusion.
Supplementary Figure 1. Blood glucose and insulin levels in mice during 4-day infusion. (A-B) WT and HT mice infused with saline or glucose had overlapping achieved blood glucose and insulin levels, necessitating
More informationMeasurement of Plasma, Serum, and Platelet Serotonin in Individuals With High Bone Mass and Mutations in LRP5
ORIGINAL ARTICLE JBMR Measurement of Plasma, Serum, and Platelet Serotonin in Individuals With High Bone Mass and Mutations in LRP5 Grace S Lee, 1 Christine Simpson, 1 Ben Hua Sun, 1 Chen Yao, 1 Dinah
More informationUpdate On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID?
Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID? Karen Aspry, MD, MS, ABCL, FACC Assistant Clinical Professor of Medicine Warren Alpert Medical School of Brown
More informationPatient Education. intermountainhealthcare.org/diabetes. BG Tracker. for people with diabetes MONITORING BLOOD GLUCOSE
Patient Education intermountainhealthcare.org/diabetes Tracker for people with diabetes MONITORING BLOOD GLUCOSE Title Case My name/phone: Contact numbers: Healthcare provider: Diabetes educator: Pharmacy:
More informationSupplementary Material 1. Statistical methods used to conduct power calculations.
Supplementary Material 1. Statistical methods used to conduct power calculations. Post-hoc power calculations and patient numbers needed to detect changes were conducted considering (i) the observed partial
More informationCost-effectiveness of Hepatitis A and Hepatitis B Vaccination for Jail Inmates
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 2007 Cost-effectiveness of Hepatitis A and Hepatitis B Vaccination
More informationSupplemental Table 1. List of primers used for real time PCR.
Supplemental Table 1. List of primers used for real time PCR. Primer Sequence Primer Sequence Mouse Pcsk9-F TTGCAGCAGCTGGGAACTT Mouse Scd1-F CATCATTCTCATGGTCCTGCT Mouse Pcsk9-R CCGACTGTGATGACCTCTGGA Mouse
More information殧 KCNJ11 11 KCNJ11 8 KCNJ11 P < KCNJ11 HDL-C. TT CT t = P =
47 2 2018 3 JOURNAL OF HYGIENE RESEARCH Vol. 47 No. 2 Mar. 2018 237 1000-8020 2018 02-0237-05 檾檾檾檾 DANONE INSTITUTE CHINA Young Scientists' Forum 檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾 KCNJ11 1 252059 11 KCNJ11
More informationJMSCR Vol 06 Issue 12 Page December 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.63 Insulinemic Status and Nonalcoholic
More informationLetter to the Editor. Association of TCF7L2 and GCG Gene Variants with Insulin Secretion, Insulin Resistance, and Obesity in New-onset Diabetes *
814 Biomed Environ Sci, 2016; 29(11): 814-817 Letter to the Editor Association of TCF7L2 and GCG Gene Variants with Insulin Secretion, Insulin Resistance, and Obesity in New-onset Diabetes * ZHANG Lu 1,^,
More informationObjectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015
Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents
More informationSupplementary Online Content
Supplementary Online Content Afkarian M, Zelnick L, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA. doi:10.1001/jama.2016.10924 emethods efigure
More informationHelpful Hints for Taking Care of Your Diabetes. Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center
Helpful Hints for Taking Care of Your Diabetes Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center Objectives How big of a problem is diabetes? What is diabetes? How is
More informationStatin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography
Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,
More informationLipoprotein Particle Profile
Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular
More informationSYNOPSIS 2/198 CSR_BDY-EFC5825-EN-E02. Name of company: TABULAR FORMAT (For National Authority Use only)
SYNOPSIS Title of the study: A randomized, double-blind, placebo-controlled, parallel-group, fixed-dose (rimonabant 20 mg) multicenter study of long-term glycemic control with rimonabant in treatment-naïve
More informationInvestigators, study sites Multicenter, 35 US sites. Coordinating Investigator: Richard Bergenstal, MD
STUDY SYNOPSIS Study number Title HMR1964A/3502 Apidra (insulin glulisine) administered in a fixed-bolus regimen vs. variable-bolus regimen based on carbohydrate counting in adult subjects with type 2
More informationEfficacy/pharmacodynamics: 85 Safety: 89
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor/Company: Sanofi Drug substance:
More informationImpact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients
2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type
More informationCorrelation of Serum Ferritin with Insulin Resistance in Type 2 Diabetes Mellitus Patients and its Relationship with Components of Metabolic Syndrome
ORIGINAL ARTICLE JIACM 2018; 19(2): 96-101 Abstract Correlation of Serum Ferritin with Insulin Resistance in Type 2 Diabetes Mellitus Patients and its Relationship with Components of Metabolic Syndrome
More informationSupplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups
Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate
More informationEffectiveness of a Multidisciplinary Patient Assistance Program in Diabetes Care
University of Rhode Island DigitalCommons@URI Senior Honors Projects Honors Program at the University of Rhode Island 2009 Effectiveness of a Multidisciplinary Patient Assistance Program in Diabetes Care
More informationCardiometabolic Side Effects of Risperidone in Children with Autism
Cardiometabolic Side Effects of Risperidone in Children with Autism Susan J. Boorin, MSN, PMHNP-BC PhD Candidate Yale School of Nursing 1 This speaker has no conflicts of interest to disclose. 2 Boorin
More informationCirculating Betatrophin Levels Are Associated with the Lipid Profile in Type 2 Diabetes
Original Article www.cmj.ac.kr Circulating Betatrophin Levels Are Associated with the Lipid Profile in Type 2 Diabetes Hassan Ghasemi, Heidar Tavilani, Iraj Khodadadi, Massoud Saidijam 1 and Jamshid Karimi*
More information25-Hydroxyvitamin D is closely related with the function of the pancreatic islet β cells
Original Article 25-Hydroxyvitamin D is closely related with the function of the pancreatic islet β cells Jingjing Guo 1, Zhengda Xiao 2, Xia Xue 3, Xin Liu 4, Yong Lu 5, Xiao Yin 6, Kun Ma 7 Open Access
More informationBy: Dr Mehrnoosh Shanaki
Resveratrol could partly improve the crosstalk between canonical β-catenin/wnt and FOXO pathways in coronary artery disease patients with metabolic syndrome: A case control study By: Dr Mehrnoosh Shanaki
More informationDiabetes Day for Primary Care Clinicians Advances in Diabetes Care
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:
More informationLipids Carbohydrate Protein. Fatty Acids Glycerol. Mono/di-saccarides. Aminoacids. Fat Liver Muscle. Triglycerides Glycogen Protein
Lipids Carbohydrate Protein Fatty Acids Glycerol Mono/di-saccarides Fat Liver Muscle Aminoacids Triglycerides Glycogen Protein Microvascular Macrovascular Diabetes-specific Diabetes-enhanced HbA1c 5.7(6.0)
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION doi:10.1038/nature11464 Supplemental Figure S1. The expression of Vegfb is increased in obese and diabetic mice as compared to lean mice. a-b, Body weight and postprandial blood
More informationFigure legends Supplemental Fig.1. Glucose-induced insulin secretion and insulin content of islets. Supplemental Fig. 2.
Figure legends Supplemental Fig.. Glucose-induced insulin secretion and insulin content of islets. Insulin secretory responses to.,., and. mm glucose (A) (n = 7-), and the insulin content in the islets
More informationEFFECT OF LYCOPENE IN TOMATO SOUP AND TOMATO JUICE ON THE LIPID PROFILE OF HYPERLIPIDEMIC SUBJECTS
EFFECT OF LYCOPENE IN TOMATO SOUP AND TOMATO JUICE ON THE LIPID PROFILE OF HYPERLIPIDEMIC SUBJECTS Nora Vigasini, Assistant Professor, Department of Home Science, Women s Christian College, Chennai, noravigas@gmail.com
More informationClinical Study Comparison of Antidiabetic Medications during the Treatment of Atherosclerosis in T2DM Patients
Hindawi Mediators of Inflammation Volume 2017, Article ID 5032708, 6 pages https://doi.org/10.1155/2017/5032708 Clinical Study Comparison of Antidiabetic Medications during the Treatment of Atherosclerosis
More informationComparative study of metabolic profile of women presenting with polycystic ovary syndrome in relation to body mass index
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Akshaya S et al. Int J Reprod Contracept Obstet Gynecol. 2016 Aug;5(8):2561-2565 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationSupplemental Table 1 Age and gender-specific cut-points used for MHO.
Supplemental Table 1 Age and gender-specific cut-points used for MHO. Age SBP (mmhg) DBP (mmhg) HDL-C (mmol/l) TG (mmol/l) FG (mmol/l) Boys 6-11 90th * 90th * 1.03 1.24 5.6 12 121 76 1.13 1.44 5.6 13 123
More informationWelcome and Introduction
Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for
More informationAssociation of serum adipose triglyceride lipase levels with obesity and diabetes
Association of serum adipose triglyceride lipase levels with obesity and diabetes L. Yang 1 *, S.J. Chen 1 *, G.Y. Yuan 1, L.B. Zhou 2, D. Wang 1, X.Z. Wang 1 and J.J. Chen 1 1 Department of Endocrinology,
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationKeywords: Type 2 DM, lipid profile, metformin, glimepiride ABSTRACT
Human Journals Research Article September 2015 Vol.:4, Issue:2 All rights are reserved by K. Saravanan et al. Effects of Monotherapy and Combination Therapy Involving Metformin and Glimepiride on HbA1c
More informationTest Definition: FNMR2 NMR LipoProfile w/ir Markers
Reporting Title: Performing Location: Labcorp Burlington Specimen Requirements: Submit only one of the following specimens: Serum Draw blood in a plain red-top tube(s). (Serum gel tube is not acceptable.)
More informationResearch Article Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance Test in a Chinese Population
Hindawi Diabetes Research Volume 2017, Article ID 3212814, 5 pages https://doi.org/10.1155/2017/3212814 Research Article Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance
More information2017 Employee Wellness Health Assessment Report
Employee Wellness National Consortium for Building Healthy Academic Communities (BHAC) Healthier Tennessee Workplace 2017 Employee Wellness Health Assessment Report Blood Pressure 2017 (387 total) (National
More informationObesity, Metabolic Syndrome, and Diabetes: Making the Connections
Obesity, Metabolic Syndrome, and Diabetes: Making the Connections Alka M. Kanaya, M.D. Associate Professor of Medicine & Epi/Biostats University of California, San Francisco February 26, 21 Roadmap 1.
More informationFructose in diabetes: Friend or Foe. Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism
Fructose in diabetes: Friend or Foe Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism Contents What is Fructose? Why is Fructose of Concern? Effects of Fructose on glycemic
More informationMetabolic Syndrome. DOPE amines COGS 163
Metabolic Syndrome DOPE amines COGS 163 Overview - M etabolic Syndrome - General definition and criteria - Importance of diagnosis - Glucose Homeostasis - Type 2 Diabetes Mellitus - Insulin Resistance
More informationSection 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for
Section 1: 1: Trends 2 Patients in the Diabetes Register 3 Diabetes Type 3 Gender of Patients with Diabetes 4 Age of Patients with Diabetes 4 Duration of Diabetes 5 Weight Control 6 Hemoglobin A1c 7 Blood
More informationPREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS
PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and
More information6/10/2016. Hui-Chun Hsu
Hui-Chun Hsu PhD, RN, CDE Chief, Department of Diabetes Management Lee s Endocrinology Clinic Pingtung, Taiwan Disclosure to Participants Conflict of Interest (COI) and Financial Relationship Disclosures:
More informationMetabolic syndrome and insulin resistance in an urban and rural adult population in Sri Lanka
Original Metabolic paper syndrome and insulin resistance in an urban and rural adult population in Sri Lanka Metabolic syndrome and insulin resistance in an urban and rural adult population in Sri Lanka
More informationSupplementary Figure 1: Additional metabolic parameters of obesity mouse models and controls. (a) Body weight, (b) blood glucose and (c) insulin
Supplementary Figure 1: Additional metabolic parameters of obesity mouse models and controls. (a) Body weight, (b) blood glucose and (c) insulin resistance index of homeostatic model assessment (HOMA IR)
More informationJUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study
Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary
More informationA pilot Study of 25-Hydroxy Vitamin D in Egyptian Diabetic Patients with Diabetic Retinopathy
A pilot Study of 25-Hydroxy Vitamin D in Egyptian Diabetic Patients with Diabetic Retinopathy El-Orabi HA 1, Halawa MR 1, Abd El-Salam MM 1, Eliewa TF 2 and Sherif NSE 1 Internal Medicine and Endocrinology
More informationبسم اهلل الرمحن الرحيم فمن شهد منكم الشهر
بسم اهلل الرمحن الرحيم فمن شهد منكم الشهر فليصمه Najat Buzaid Introduction Ramadan is a lunar-based month, and its duration varies between 29 and 30 days. The fasting hours vary from 10 hours in a temperature
More informationSUPPLEMENTARY FIGURES
SUPPLEMENTARY FIGURES Figure S1. Effect of a HFD on the Acox gene expression in the livers of WT and IL-6 -/- mice. Expression of Acox in the livers of WT and IL-6 -/- mice fed STD or HFD determined through
More informationObesity and Insulin Resistance According to Age in Newly Diagnosed Type 2 Diabetes Patients in Korea
https://doi.org/10.7180/kmj.2016.31.2.157 KMJ Original Article Obesity and Insulin Resistance According to Age in Newly Diagnosed Type 2 Diabetes Patients in Korea Ju Won Lee, Nam Kyu Kim, Hyun Joon Park,
More informationASSESSMENT OF INSULIN RESISTANCE AND Apo B / Apo A1 RATIO IN TYPE II DIABETES PATIENTS
ORIGINAL ARTICLE ASSESSMENT OF INSULIN RESISTANCE AND Apo B / Apo A RATIO IN TYPE II DIABETES PATIENTS 2 3 RP.Sathvika, Philips Abraham, R.Sudha, Evangeline Jones Background: Insulin resistance (IR) is
More informationEffectiveness Of A Diabetic Ketoacidosis Prevention Intervention In Children With Type 1 Diabetes
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Public Health Theses School of Public Health January 2015 Effectiveness Of A Diabetic Ketoacidosis Prevention Intervention
More informationAndré J. Tremblay, 1 Benoît Lamarche, 1 Jean-Charles Hogue, 1 and Patrick Couture 1,2. 1. Introduction. 2. Methods
Diabetes Research Volume 2016, Article ID 2909210, 5 pages http://dx.doi.org/10.1155/2016/2909210 Clinical Study n-3 Polyunsaturated Fatty Acid Supplementation Has No Effect on Postprandial Triglyceride-Rich
More informationLab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure.
Patient Education Lab Values Explained Common Tests to Help Diagnose Kidney Disease Lab work, urine samples and other tests may be given as you undergo diagnosis and treatment for renal failure. The test
More informationSupplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms
Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±
More informationSupplemental Information. Human Carboxylesterase 2 Reverses. Obesity-Induced Diacylglycerol Accumulation. and Glucose Intolerance
Cell Reports, Volume 18 Supplemental Information Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance Maxwell A. Ruby, Julie Massart, Devon M. Hunerdosse,
More informationRegulation of GLUT4 glucose transporter trafficking
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 9-10-2010 Regulation of GLUT4 glucose transporter trafficking Leah
More informationRoux-and-Y Gastric Bypass and its Metabolic Effects
Roux-and-Y Gastric Bypass and its Metabolic Effects Nicola Di Lorenzo President elect of SICOb Italian Society for Bariatric Surgery and Metabolic Diseases Dept. of General Surgery-Università di Roma Tor
More informationPREDIABETES TESTING SERVICES
PREDIABETES TESTING SERVICES ASSESSING DIABETES RISK IN ASYMPTOMATIC ADULTS Depending upon population characteristics, up to 70% of individuals with prediabetes will ultimately progress to diabetes at
More informationResearch Article Increased Serum Pigment Epithelium-Derived Factor in Women with Gestational Diabetes Is Associated with Type 2 Diabetes
International Endocrinology Volume 2015, Article ID 346938, 5 pages http://dx.doi.org/10.1155/2015/346938 Research Article Increased Serum Pigment Epithelium-Derived Factor in Women with Gestational Diabetes
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationPREVALENCE OF INSULIN RESISTANCE IN FIRST DEGREE RELATIVES OF TYPE-2 DIABETES MELLITUS PATIENTS: A PROSPECTIVE STUDY IN NORTH INDIAN POPULATION
PREVALENCE OF INSULIN RESISTANCE IN FIRST DEGREE RELATIVES OF TYPE-2 DIABETES MELLITUS PATIENTS: A PROSPECTIVE STUDY IN NORTH INDIAN POPULATION Arvind Kumar, Poornima Tewari, Sibasis S. Sahoo and Arvind
More informationLIPOPROTEINE ATEROGENE E ANTI-ATEROGENE ATEROGENE
LIPOPROTEINE ATEROGENE E ANTI-ATEROGENE ATEROGENE Sebastiano Calandra Dipartimento di Scienze Biomediche Università di Modena e Reggio Emilia Incidence Rate/1000 200-150 - 100-50 - Women 0 Men
More informationTRIGLYCERIDE/HIGH-DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION RATIO IDENTIFIES ACCENTUATED CARDIO-METABOLIC RISK
ENDOCRINE PRACTICE Rapid Electronic Article in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited, typeset
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationSupplementary Figure S I: Effects of D4F on body weight and serum lipids in apoe -/- mice.
Supplementary Figures: Supplementary Figure S I: Effects of D4F on body weight and serum lipids in apoe -/- mice. Male apoe -/- mice were fed a high-fat diet for 8 weeks, and given PBS (model group) or
More informationATP III (Adult Treatment Panel III) CLASSIFICATION C IN ADULTS
LABORATORY AND RISK FACTORS OF ATHEROSCLEROSIS S R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty RISK FACTORS FOR CHD Clinical Risk Factors Laboratory Risk Factors MAJOR CLINICAL RISK
More informationWhat s New in Bariatric Surgery?
Bariatric Surgery: Update for the General Surgeon What s New in Bariatric Surgery? 2,000 B.C. 2,000 A.D. 1. America keeps getting fatter without an end in sight. 2. Bariatric surgery is not just about
More informationKaren Olson, 1 Bryan Hendricks, 2 and David K. Murdock Introduction. 2. Methods
Cholesterol Volume 2012, Article ID 794252, 4 pages doi:10.1155/2012/794252 Research Article The Triglyceride to HDL Ratio and Its Relationship to Insulin Resistance in Pre- and Postpubertal Children:
More informationGender: M Chart No: Fasting: Yes. Boston Heart HDL Map TM Test 1 ApoA-I (mg/dl) levels in HDL particles. α Range > <14 mg/dl. α-2 50.
Pro vider: Ordering Provider 123 Main Street Anytown, ST 12345 Account No: DOB: 00/00/1950 Framingham Risk Score: Patient Info: FAMILY HIST CVD Lipid, Lipoprotein and Apolipoprotein Tests Total Cholesterol
More informationImplications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?
Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationHormonal Regulations Of Glucose Metabolism & DM
Hormonal Regulations Of Glucose Metabolism & DM What Hormones Regulate Metabolism? What Hormones Regulate Metabolism? Insulin Glucagon Thyroid hormones Cortisol Epinephrine Most regulation occurs in order
More informationTesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies
Tesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies Copyright 2016. All Rights Reserved. Property of Theratechnologies Inc. Mechanism of Action of Tesamorelin
More informationInsulin Secretion and Sensitivity during Oral Glucose Tolerance Test in Korean Lean Elderly Women
J Korean Med Sci 2001; 16: 592-7 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences Insulin Secretion and Sensitivity during Oral Glucose Tolerance Test in Korean Lean Elderly Women Impaired
More information